Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 147,703 | 120,179 | 57,936 | 168,740 | 66,764 |
| Marketable Securities | 220,310 | 301,083 | 296,590 | 300,474 | 138,217 |
| Receivables | 97,730 | 59,442 | 30,005 | 22,133 | 15,680 |
| Inventories | 60,747 | 29,359 | 22,625 | 5,146 | 14,623 |
| TOTAL | $554,764 | $543,436 | $427,849 | $510,372 | $256,532 |
| Non-Current Assets | |||||
| PPE Net | 10,593 | 10,855 | 7,465 | 3,520 | 4,264 |
| Other Non-Current Assets | 14,567 | 11,583 | 4,934 | 6,053 | 719 |
| TOTAL | $25,160 | $22,438 | $12,399 | $9,573 | $4,983 |
| Total Assets | $579,924 | $565,874 | $440,248 | $519,945 | $261,515 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 397,228 | 19,542 | 91,506 | 77,211 | 17,393 |
| Accounts payable and accrued liabilities | 1,928 | 6,434 | 4,079 | 7,948 | 3,578 |
| Accrued Expenses | 20,483 | 55,649 | 49,529 | 39,601 | 28,821 |
| TOTAL | $421,385 | $85,637 | $149,361 | $131,328 | $54,585 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 383,045 | 34,874 | 125,140 | 199,228 |
| Deferred Revenues | 1,746 | 4,012 | 4,247 | 6,568 | 4,793 |
| Other Non-Current Liabilities | 3,466 | 4,180 | 2,118 | 814 | 358 |
| TOTAL | $7,492 | $388,472 | $42,000 | $180,251 | $239,411 |
| Total Liabilities | $428,877 | $474,109 | $191,361 | $311,579 | $293,996 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 135,276 | 138,226 | 145,033 | 143,077 | 129,764 |
| Common Shares | 135 | 137 | 145 | 143 | 130 |
| Retained earnings | -474,593 | -603,678 | -531,438 | -522,371 | -585,342 |
| Other shareholders' equity | 22 | 240 | -277 | -450 | -6 |
| TOTAL | $151,047 | $91,765 | $248,887 | $208,366 | $-32,481 |
| Total Liabilities And Equity | $579,924 | $565,874 | $440,248 | $519,945 | $261,515 |